Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

FINDELL CAPITAL MANAGEMENT LLC 13F Holdings -- Portfolio & Top Positions (2026-03-31)

FINDELL CAPITAL MANAGEMENT LLC (CIK 1814465) reported $341.4M across 16 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: LQDA ($134.1M, 39.26%), ESTA ($56.7M, 16.59%), DAVE ($29.6M, 8.67%), ROOT ($16.6M, 4.85%), SGHC ($16.2M, 4.74%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1LQDALIQUIDIA CORPORATION$134.1M39.26%3.6MTrimmed
2ESTAESTABLISHMENT LABS HLDGS INC$56.7M16.59%997,747Trimmed
3DAVEDAVE INC$29.6M8.67%170,000Added
4ROOTROOT INC$16.6M4.85%375,000Added
5SGHCSUPER GROUP SGHC LIMITED$16.2M4.74%1.5MAdded
6GEOGEO GROUP INC$14.7M4.31%875,000Added
7OPRTOPORTUN FINL CORP$12.7M3.71%2.7MAdded
8ABVXABIVAX SA$11.7M3.42%105,000Added
9CVECENOVUS ENERGY INC$9.9M2.91%375,000New
10ACHCACADIA HEALTHCARE COMPANY IN$8.9M2.60%380,000New
11TPBTURNING PT BRANDS INC$8.2M2.41%95,000Trimmed
12CELHCELSIUS HLDGS INC$7.1M2.08%200,000Trimmed
13MLYSMINERALYS THERAPEUTICS INC$5.5M1.60%202,000Added
14VETVERMILION ENERGY INC$5.1M1.49%370,000New
15APLDAPPLIED DIGITAL CORP$4.0M1.18%170,000New
16BTUPEABODY ENGR CORP$276,1540.08%8,381New
17EHTHEHEALTH INC$230,9450.07%179,027Trimmed
18ADMAADMA BIOLOGICS INC$00.00%0Exited
19LRNSTRIDE INC$00.00%0Exited
20VORVOR BIOPHARMA INC$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-03-31